Cutler Group’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-19,900
| Closed | -$1.69M | – | 5820 |
|
|
2020
Q3 | $1.69M | Buy |
19,900
+10,600
| +114% | +$536K | 0.1% | 199 |
|
|
2020
Q2 | $329K | Buy |
9,300
+4,900
| +111% | +$143K | 0.02% | 637 |
|
|
2020
Q1 | $59K | Sell |
4,400
-5,072
| -54% | -$85.3K | ﹤0.01% | 1631 |
|
|
2019
Q4 | $200K | Sell |
9,472
-1,528
| -14% | -$27K | 0.01% | 824 |
|
|
2019
Q3 | $145K | Buy |
11,000
+6,000
| +120% | +$88.2K | 0.01% | 865 |
|
|
2019
Q2 | $69K | Buy |
5,000
+1,000
| +25% | +$15K | 0.01% | 1324 |
|
|
2019
Q1 | $76K | Buy |
4,000
+3,800
| +1,900% | +$61.2K | 0.01% | 1170 |
|
|
2018
Q4 | $2K | Buy |
+200
| New | +$3.97K | ﹤0.01% | 3504 |
|
|
2017
Q4 | – | Sell |
-1,307
| Closed | -$15.4K | – | 6361 |
|
|
2017
Q3 | $18K | Sell |
1,307
-593
| -31% | -$5.91K | ﹤0.01% | 3250 |
|
|
2017
Q2 | $16K | Sell |
1,900
-700
| -27% | -$4.92K | ﹤0.01% | 3687 |
|
|
2017
Q1 | $16K | Buy |
2,600
+1,879
| +261% | +$9.52K | ﹤0.01% | 3584 |
|
|
2016
Q4 | $2K | Buy |
+721
| New | +$2.13K | ﹤0.01% | 5789 |
|
|
2016
Q3 | – | Sell |
-5,000
| Closed | -$14K | – | 7666 |
|
|
2016
Q2 | $11K | Buy |
+5,000
| New | +$16.7K | ﹤0.01% | 4071 |
|
|
2016
Q1 | – | Sell |
-8,561
| Closed | -$19.3K | – | 7503 |
|
|
2015
Q4 | $26K | Buy |
+8,561
| New | +$23.9K | ﹤0.01% | 3159 |
|
Cutler Group's IMMU Position: Q4 2020 in Review
Cutler Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 19,900 shares — an estimated $1.69M sold.
Cutler Group first reported a position in IMMU in Q4 2015 and held it in 14 quarters. The position peaked at $1.69M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Cutler Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Cutler Group sold 19,900 Immunomedics Inc shares in Q4 2020, an estimated $1.69M.
- Cutler Group first reported a position in Immunomedics Inc in Q4 2015 and held it in 14 quarters.
- Cutler Group's Immunomedics Inc position peaked at $1.69M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.